With Dueling Papers Comes A Spirited Debate About Stapled Peptides
This article was originally published in Start Up
Executive Summary
The new, promising class of drugs is rolling toward the clinic, but a respected research group recently thrust a stick in the spokes and prompted a call for wider access to the technology.